FUN WITH FINANCES
Series A investments boost 2013 for VC-backed biopharmas
By Brian Orelli
Monday, January 6, 2014
U.S. biopharmaceutical companies capped 2013 with the strongest quarter of the year, raising $835 million in 37 venture capital deals in the fourth quarter according to data compiled by BioWorld Snapshots.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.